Upon activation by T cell--dependent (TD) antigens, naive B cells are recruited into germinal centers (GCs; [@bib23]). With appropriate stimulation by helper T cells and dendritic cells, the GC B cells clonally expand, diversify their Ig variable (IgV) region genes by somatic hypermutation (SHM), and are selected for increased affinity of their B cell receptor (BCR; [@bib29]). Independent from the process of SHM, class switching of the Ig heavy chain constant region from IgM to downstream Ig isotypes occurs in GC B cells ([@bib35]; [@bib13]). Accordingly, somatically mutated IgV genes in combination with the expression of a class-switched BCR were considered as the hallmarks of the descendents of GC B cells, i.e., memory B cells and post-GC plasma cells ([@bib14]; [@bib44]).

Approximately 10 yr ago, two IgM^+^ B cell subsets with mutated V genes were described in humans; they are a population of cells characterized by high expression of IgM but low IgD surface levels (IgM-only B cells) and IgM^+^IgD^+^CD27^+^ B cells ([@bib16], [@bib17]; [@bib39]). Nearly all cells of these subsets carry somatically mutated IgV genes, but their mean mutation load is ∼50--60% of that of class-switched memory B cells. As both mutated IgM^+^ B cell populations and the class-switched memory B cells share expression of the TNF-receptor superfamily member CD27, whereas unmutated naive B cells lack its expression, this marker was proposed to represent a general human memory B cell marker ([@bib1]; [@bib17]). The idea that the two IgM^+^ B cell subsets with mutated V genes are GC-derived memory B cells was supported by the observations that these cells are rare in newborn infants but accumulate with age ([@bib1]; [@bib50]), are long-lived ([@bib31]), show a propensity like class-switched memory B cells to differentiate into Ig-secreting cells upon appropriate stimulation ([@bib1]; [@bib5], [@bib6]; [@bib37]), and respond in vitro to various stimuli more similar to class-switched memory cells than to naive B cells ([@bib40], [@bib41]; [@bib12]; [@bib11]).

However, recent studies on human IgM^+^IgD^+^CD27^+^ B cells indicated that other mechanisms might be responsible for the generation and maintenance of these cells. Based on a reported dependency of these cells on the splenic environment, which is known to be important for T cell--independent (TI) type II immune responses, it was proposed that IgM^+^IgD^+^CD27^+^ (as well as IgM-only B cells, which were not distinguished in that work) are generated in TI responses ([@bib18]). In another scenario, it was proposed that the mutated IgM^+^IgD^+^CD27^+^ B cells underwent SHM in a primary, antigen-independent diversification mechanism outside GC, as it is known to occur in sheep and rabbits ([@bib43]; [@bib30]). This idea was based on the observation that x-linked hyper-IgM patients apparently lack GC (caused by defective CD40L-signaling) and class-switched, as well as IgM-only, B cells, but still have substantial numbers of mutated IgM^+^IgD^+^CD27^+^ B cells ([@bib45], [@bib46]). Several findings supported this scenario, including an analysis of CDRIII length diversity of the respective subsets, particularly the presence of rare mutated IgM^+^CD27^+^ B cells in fetal liver ([@bib33]) and neonatal cord blood ([@bib45]), as well as the detection of transcripts of activation-induced cytidine deaminase, an enzyme that is essential for SHM and class switching, in human cord blood transitional type 1/immature B cells ([@bib20]).

As IgM^+^IgD^+^CD27^+^ B cells and IgM-only B cells account for ∼15 and 5% of human peripheral blood B cells, respectively, and occur at similar frequencies also in secondary lymphoid tissues ([@bib25]; [@bib9]), the cellular origin and functions of about a quarter of human mature B cells are currently controversially discussed.

To clarify whether mutated IgM^+^ B cells are post-GC cells, we analyzed molecular footprints of GC reactions in human B cell subsets. It has been shown that Bcl6, the master transcriptional regulator in GC B cells ([@bib15]), is affected by the SHM machinery in GC B cells, resulting in ∼30% of GC and class-switched memory B cells carrying *Bcl6* mutations in the intronic major mutation cluster (MMC; [@bib26]; [@bib36]; [@bib28]). As SHM of IgV and non-Ig genes is strictly dependent on high-level transcription of the target sequences ([@bib10]; [@bib3]; [@bib47]), *Bcl6* should only be mutated in GC B cells that express high levels of this gene, but not in non-GC B cells that lack *Bcl6* expression or show only low transcript levels. Thus, if the vast majority of IgM^+^CD27^+^ B cells acquired somatic IgV gene mutations in a GC-independent way, and hence in the absence of *Bcl6* transcription, these cells should lack *Bcl6* mutations. Second, if IgM^+^IgD^+^CD27^+^ and class-switched B cells derive from common GC B cell clones, one may find clonally related IgM^+^IgD^+^CD27^+^ and class-switched B cells in the PB, and these cells should carry shared and distinct somatic V gene mutations.

RESULTS
=======

*Bcl6* mutations in human CD27^+^ B cell subsets
------------------------------------------------

We analyzed the mutation status of the *Bcl6*-MMC in FACS-sorted B cells from three healthy adult blood donors by single-cell PCR. This approach allows the reliable detection of rare mutations, as PCR-introduced mutations are negligible in the direct sequence analysis of the amplificates from single cells. As it is relevant for the determination of the mutation frequency whether one or both alleles of a cell were amplified, we analyzed donors who were prescreened to carry a known single-nucleotide polymorphism (SNP; rs3832246, 1 bp deletion) on one allele of *Bcl6*, so that for unmutated sequences it could also be determined whether one or both alleles were amplified. Overall, from ∼21% of the cells (range 14--25%) both alleles were amplified ([Table I](#tbl1){ref-type="table"}). The *Bcl6*-MMC of all 60 PCR-positive naive B cells was unmutated, whereas 16 of 75 (21%) IgM^+^IgD^+^CD27^+^ B cells, 13 of 64 (20%) IgM-only, and 19 of 57 (33%) class-switched B cells carried mutations. In the CD27^+^ B cell subpopulations, 8--12 cells had a single mutation and 4--9 cells harbored 2--6 mutations per sequence. The mean mutation frequencies were 0.045% (range 0.036--0.084%) for IgM^+^IgD^+^CD27^+^ B cells, 0.050% (range 0.013--0.119%) for IgM-only B cells, and 0.085% (range 0.082--0.093%) for class-switched B cells. Thus, IgM^+^IgD^+^CD27^+^ and IgM-only B cells carry class-switched B cells in a fraction of cells *Bcl6* mutations as a footprint of a GC passage of these B cells. The mutations were distributed throughout the whole MMC, and besides two 1-bp deletions and one 5-bp deletion, the mutations were single basepair substitutions with a bias for transitions in IgM^+^IgD^+^CD27^+^, IgM-only, and class-switched B cells (63, 58, and 46%, respectively, as compared with an expected frequency of 33% for unbiased mutations). The overrepresentation of transitions over transversions was statistically significant only for both IgM^+^ B cell subsets (P \< 0.001 each), but not in those of class-switched B cells (P \< 0.09). The RGYW and WRCY motifs are known SHM hotspots ([@bib32]), and each of the three CD27^+^ B cell subsets had an enrichment of mutations in RGYW/WRCY motifs. 28.6% of the mutations in IgM^+^IgD^+^CD27^+^, 18.5% in IgM-only, and 40.5% in class-switched B cells were within the motifs, in comparison to an expected frequency of 16.7%, assuming unbiased targeting of these motifs. The difference between observed and randomly expected targeting of RGYW/WRCY motifs reached statistical significance only for class-switched B cells (P \< 0.001). However, in another study *Bcl6* mutations in class-switched B cells from human tonsil also did not show significant RGYW targeting ([@bib48]). The fact that the intrinsic SHM biases analyzed did not reach statistical significance in all instances might be caused by the restricted number of mutation events analyzed and/or by the fact that some *Bcl6* mutations influence *Bcl6* expression ([@bib27]) and hence may be selected for or against.

###### 

*Bcl6* mutations in human PB B cells

  Donor   Cell type             PCR efficiency[a](#tblfn1){ref-type="table-fn"}   1 allele/2 alleles amplified[b](#tblfn2){ref-type="table-fn"}   Mutated cells   Number of mutations[c](#tblfn3){ref-type="table-fn"}   Mutation frequency[d](#tblfn4){ref-type="table-fn"}
  ------- --------------------- ------------------------------------------------- --------------------------------------------------------------- --------------- ------------------------------------------------------ -----------------------------------------------------
                                                                                                                                                  (%)                                                                    \%
  A       naive                 26/50                                             22/4                                                            0               0                                                      0
          IgM^+^IgD^+^CD27^+^   31/50                                             22/9                                                            7 (23)          6 × 1, 1 × 2                                           0.039
          IgM-only              26/50                                             21/5                                                            5 (19)          5 × 1                                                  0.024
          class switched        18/50                                             16/2                                                            6 (33)          4 × 1, 1 × 2, 1 × 5                                    0.082
  B       naive                 18/50                                             11/7                                                            0               0                                                      0
          IgM^+^IgD^+^CD27^+^   25/50                                             21/4                                                            5 (20)          4 × 1, 1 × 3                                           0.036
          IgM-only              20/50                                             15/5                                                            6 (30)          1 × 1, 2 × 2, 1 × 4, 1 × 5, 1 × 6                      0.119
          class switched        24/50                                             19/5                                                            8 (33)          4 × 1, 2 × 2, 1 × 3, 1 × 5                             0.082
  C       naive                 16/40                                             12/4                                                            0               0                                                      0
          IgM^+^IgD^+^CD27^+^   19/40                                             15/4                                                            4 (21)          2 × 1, 1 × 5, 1 × 6                                    0.084
          IgM-only              18/40                                             13/5                                                            2 (11)          2 × 1                                                  0.013
          class switched        15/40                                             14/1                                                            5 (33)          2 × 1, 2 × 2, 1 × 4                                    0.093
  mean    naive                 60/140                                            45/15                                                           0               0                                                      0
          IgM^+^IgD^+^CD27^+^   75/140                                            58/17                                                           16 (21)         12 × 1, 1 × 2, 1 × 3, 1 × 5, 1 × 6                     0.045
          IgM-only              64/140                                            49/15                                                           13 (20)         8 × 1, 2 × 2, 1 × 4, 1 × 5, 1 × 6                      0.050
          class switched        57/140                                            49/8                                                            19 (33)         10 × 1, 5 × 2, 1 × 3, 1 × 4, 2 × 5                     0.085

Numbers of positive PCRs versus single cells analyzed.

Number of PCR products containing one/two alleles.

In A × B, A denotes the number of sequences with B mutations.

The percentage of mutations in a total of 670 bp of the *Bcl6*-MMC considered from each sequence.

Clonal relation of human IgM^+^IgD^+^CD27^+^ and class-switched memory B cells
------------------------------------------------------------------------------

If IgM^+^ memory B cells and class-switched B cells both are descendants of common GC B cell clones, it should principally be possible to find clonally related IgM^+^ and IgG^+^ B cells with shared and unique mutations in PB. We focused on IgM^+^IgD^+^CD27^+^ B cells because their origin is more controversial than that of IgM-only B cells ([@bib45]), and for our analysis it would have been difficult to obtain enough cells from the small IgM-only subset.

Our first approach to identify such clonally related cells was based on a PAGE strategy and aimed at very large clones. Considering the number of cells that could be used per PCR reaction (30,000) and the total number of IgG^+^CD27^+^ and IgM^+^IgD^+^CD27^+^ B cells in the PB (∼6 × 10^8^ per subset), we calculated that a putative clone should have at least 20,000 members in each of the two subsets to be detectable by this approach. Several aliquots of 30,000 IgG^+^CD27^+^ and IgM^+^IgD^+^CD27^+^ B cells each were sorted from PB of 10 healthy donors. Extracted RNA was separately reverse transcribed with gene-specific primers for Cγ and Cμ/Cδ and amplified with a V~H~1 family-specific primer and the same Cγ and Cμ/Cδ primers ([Fig. 1 A](#fig1){ref-type="fig"}). The Cγ primer used in this and the experiment described further below is specific for the Cγ1 and Cγ3 genes, which are classically used by post-GC memory B cells, but does not amplify Cγ2 transcripts, which mainly derive from TI responses ([@bib34]). All C~H~ primers were complementary to positions in equal distance from the first coding nucleotide of the corresponding C~H~ gene. Thus, an identical CDRIII length of putative clone members in IgM^+^IgD^+^CD27^+^ and IgG^+^CD27^+^ B cells would result in equal-size products in a CDRIII-spectratyping analysis, performed on neighboring lanes of a PAGE gel. Such bands of interest were cut out from the gel, reamplified, and sequenced. Overall, 120 pairs of identical length were analyzed from sorted cells of the 10 donors. Most of these products (85%) were oligo- to polyclonal and not further followed up. From the monoclonal products in one instance, clonally related *V~H~1-18*--expressing IgM and IgG transcripts were obtained, and after cloning of the amplificates 7 distinct IgG^+^ and 2 distinct IgM^+^ members of the clone were identified ([Fig. 2 A](#fig2){ref-type="fig"}). The clone members contained between 3 and 9 V~H~ gene mutations per sequence, of which 1 to 7 were shared by at least two clone members. Importantly, the genealogical tree depicting the most likely clonal evolution revealed that several IgG^+^ clone members descended from a proposed intermediate with only a single point mutation, whereas the two IgM sequences shared 5 additional point mutations with the other IgG^+^ sequences. We conclude that the IgM^+^ B cells acquired most if not all of their mutations in the clonal evolution of the GC B cell clone that gave rise to these memory B cells.

![**Flow charts of the experimental approaches used to identify clonally related sequences in PB IgM^+^ and IgG^+^ B cells.** (A) PAGE--based approach. (B) CDRIII-specific primer−based approach.](JEM_20091087_LW_Fig1){#fig1}

![**Genealogic trees of *V~H~1-18*--, *V~H~6*-, or *V~H~3-23*--expressing memory B cell clones, reconstructed from clonally related IgM^+^ and IgG^+^ sequences.** Abbreviations in the circles represent single sequences from IgM^+^ (M) or IgG^+^ (G) B cells, empty circles represent hypothetical intermediates. Gp denotes the IgG^+^ B cell sequence that was used to design the clone-specific primer. Numbers besides the lines indicate the number of (additional) somatic mutations acquired from a given cell to its descendent. Each tree is rooted by the putative, unmutated V~H~ rearrangement, marked as "gl" (the roots of clones E, G, and L also include unmutated members). The trees were constructed to maximize the number of shared and minimize the number of unique mutations. In rare instances, a reversion of a formerly shared mutation was assumed to ensure consistency of the dendrogram. Importantly, the overall shape of the respective tree was never affected. In two instances (clones H and M), the development of IgG clones members could principally be explained by two independent prediversified IgM clone members (marked with an "x") entering GC reactions. (A) Includes M1, M2, G6-13, and G17-21. (B) Includes M1, M2, M6, M8, M10, G1, G4, G5, G7, G9, and Gp. (C) Includes M2, M7, M14, M19, M20, M24, M28, M31, M33, M37, M39, M40, G1, G5, G7, G8, G10, G17, G21-24, and G29. (D) Includes M2-6, M9, G4, G9, G18, G19, G21-23, G27, and Gp. (E) Includes M15, M28, M43, M49, and M63. (F) Includes M1-4, M6, M10, G1, G3, and G9. (G) Includes M12, M21, G4, G7, G8, and G10. (H) Includes M13, M20, M23, and M26-28. (I) Includes G3-5, G7, G8, G10-12, G15, and G18. (J) Includes M1-3, M8, M10, M12, and M15. (K) Includes M3, M4, M6, M9, and M10. (L) Includes M2, M8, M10, and M15. (M) Includes G10, G11, G14, and Gp. (N) Includes G3, G9, G10, G14, G15, and G17. (O) The number of mutations includes a 3-bp deletion in sequence G31. The number of mutations includes a 3-bp insertion in all downstream sequences.](JEM_20091087_GS_Fig2){#fig2}

As the gel-based approach was restricted by the relatively small number of cells that could be analyzed for a clonal relationship, we established an RT-PCR--based approach with clone-specific primers to screen larger cell samples ([Fig. 1 B](#fig1){ref-type="fig"}). RNA from 10^6^ to 1.5 × 10^6^ sorted IgG^+^ and IgM^+^IgD^+^CD27^+^ B cells isolated from 8 adult peripheral blood donors, and in two instances from naive B cells (donors 7 and 8), was extracted and reverse transcribed with Cγ and Cμ/Cδ primers, respectively. The cDNAs from both subsets were amplified with primers for *V~H~6*-FR1 (donors 1--6) or *V~H~3-23* leader peptide sequence (donors 7 and 8) in combination with nested constant region primers. The nesting effect of the second constant primer set prevents the amplification of V~H~D~H~J~H~-rearrangements from potential cell sorting contaminations, i.e., IgM transcripts from an IgG^+^ B cell sort and vice versa. By analyzing the single member *V~H~6* family, we aimed to enhance the chance to find clonally related cells caused by a reduced heterogeneity of the population. However, as *V~H~3-23* is one of the most frequently used V~H~ gene segments ([@bib8]), we aimed to clarify whether clonally related IgM^+^IgD^+^ and IgG^+^ B cells can also be found for such a gene segment. The amplified *V~H~6* and *V~H~3-23* rearrangements of IgG^+^ B cells were cloned and a number of sequences (8 to 30 per PB donor) were randomly chosen to design CDRIII-specific primers. These primers were mainly binding to the 3′ end of CDRIII (and in several instances parts of FRIV), so that enough sequence from the 5′ part of CDRIII was included in the resulting amplificates to allow an unequivocal determination of the clonal relationship of the amplified rearrangements. The CDRIII primers were used together with the *V~H~6* or *V~H~3-23* primer to amplify clonally related sequences from the *V~H~6*-Cμ/Cδ-- or *V~H~3-23*-Cμ/Cδ--amplified cDNA from IgM^+^IgD^+^CD27^+^ B cells, respectively.

From donors 1--6, we were able to amplify and directly sequence 21 monoclonal PCR products from *V~H~6*-expressing IgM^+^IgD^+^CD27^+^ B cells (range 2--5 per donor; oligo- or polyclonal amplificates caused by cross-hybridization of the "clone-specific" primers on other *V~H~6* gene rearrangements were not further considered). Of these 21 products, 11 *V~H~6* rearrangements from IgM^+^IgD^+^CD27^+^ B cells were clonally related to the respective V~H~6 rearrangements from the IgG^+^ B cells ([Table II](#tbl2){ref-type="table"}). From donors 7 and 8, we obtained 9 and 7 monoclonal PCR products, respectively, from *V~H~3-23*--expressing IgM^+^IgD^+^CD27^+^ B cells. Of these 16 products, 3 *V~H~3-23* rearrangements from IgM^+^IgD^+^CD27^+^ B cells were clonally related to the respective *V~H~3-23* rearrangements from the IgG^+^ B cells ([Table II](#tbl2){ref-type="table"}). With the "clone-specific" primers for these three memory B cell clones, no clonally related sequences were obtained from the corresponding naive B cells, although 14--21 sequences from the cloned PCR amplificates were analyzed for the three clones. Instead, the sequences from the naive B cells consisted of 4--10 different unmutated sequences with varying CDRIII length and composition ([Fig. S1](http://www.jem.org/cgi/content/full/jem.20091087/DC1)). As one would not expect to find naive B cell clone members among the isolated cells, the lack of CDRIII sequences shared by the naive and IgG^+^ B cells validates the reliability of the approach to identify clonally related sequences among the mutated IgD^+^IgM^+^ and IgG^+^ B cells.

###### 

Clones with IgM^+^ and IgG^+^ members in human PB memory B cells

  Donor   V~H~-gene analyzed   CD27^+^ B cells   CDRIII primers[a](#tblfn5){ref-type="table-fn"}   Products with monoclonal CDRIII[b](#tblfn6){ref-type="table-fn"}   Clones with IgM and IgG members[c](#tblfn7){ref-type="table-fn"}
  ------- -------------------- ----------------- ------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------
                               \%                                                                  (%)                                                                (%)
  1       *V~H~6*              30                15                                                5 (33)                                                             2 (40)
  2       *V~H~6*              40                20                                                2 (10)                                                             0
  3       *V~H~6*              45                20                                                3 (15)                                                             0
  4       *V~H~6*              30                15                                                3 (20)                                                             3 (100)
  5       *V~H~6*              25                8                                                 4 (38)                                                             2 (50)
  6       *V~H~6*              19                8                                                 4 (50)                                                             4 (100)
  7       *V~H~3-23*           29                30                                                9 (30)                                                             1 (11)
  8       *V~H~3-23*           21                30                                                7 (23)                                                             2 (29)

Number of CDRIII-primers which amplified a specific product from diluted DNA of the respective IgG^+^ B cell clone.

Counted are only those products which gave rise to a sequence with distinct CDRIII, i.e. those where the CDRIII-primer specified a unique clone.

The number of clones with IgM^+^ and IgG^+^ B cells. The frequency of clones among monoclonal products is shown in brackets.

To study the intraclonal diversity of the clonally related V~H~-Cμ and V~H~-Cγ amplificates, for each of the 11 *V~H~6* and 3 *V~H~3-23* clones, PCR products obtained with the CDRIII-specific primers from the IgG^+^ and IgM^+^IgD^+^CD27^+^ B cells were cloned into plasmids and several of these were sequenced. Sequence alignments of five selected sequences per clone, including the initial IgG sequence, are depicted in [Fig. S2](http://www.jem.org/cgi/content/full/jem.20091087/DC1).

For all 14 clones expressing *V~H~6* or *V~H~3-23*, multiple distinct members, differing from each other by single, few, or \>24 point mutations were found ([Fig. 2](#fig2){ref-type="fig"}). The overall mutation frequency of the IgG^+^CD27^+^ B cells (including clone A from the PAGE analysis) is 6.2% and of the IgM^+^IgD^+^CD27^+^ B cells 4.2%. Genealogical trees were generated to visualize the mutational evolution of the clones, and a heterogenous picture was obtained ([Fig. 2](#fig2){ref-type="fig"}). Moreover, in 6 clones, IgM members are mainly early progeny of the clones and hence carry relatively few mutations ([Fig. 2](#fig2){ref-type="fig"}, clones H-M), whereas the IgG^+^ post-GC B cells -- with few exceptions -- have acquired more shared and distinct mutations. In the other 9 clones, including clone A ([Fig. 2, A--G, N, and O](#fig2){ref-type="fig"}), IgG^+^ and IgM^+^ clone members are found more intermingled. Notably, also in these trees, IgG sequences on average carry more mutations than IgM sequences. Unmutated IgM^+^ sequences were detected in two clones ([Fig. 2, E and L](#fig2){ref-type="fig"}), and unmutated IgM and IgG sequences were detected in one clone ([Fig. 2 G](#fig2){ref-type="fig"}).

Considering the overall shapes of the trees depicting the clonal evolution of the B cell clones, a striking diversity is evident. Each clone consists of a high number of branches, and many distinct sequences were found. This shows that throughout the GC reaction, and starting early during clonal expansion and mutation accumulation, clone members are selected to leave the GC and become members of the memory B cell pool.

Assuming that all clone members in a sample were detected (certainly an underestimation), we estimated the total number of clone members in the PB of the donors. Counting repeatedly identified sequences only once, we calculated a clone size of 190 B cells for the smallest clone ([Fig. 2](#fig2){ref-type="fig"}) and 3,600 B cells for the largest clone ([Fig. 2 M](#fig2){ref-type="fig"}) detected in our study (see Materials and methods).

DISCUSSION
==========

Human IgM-only and IgM^+^IgD^+^CD27^+^ B cell subsets carry molecular footprints of a GC reaction
-------------------------------------------------------------------------------------------------

To clarify the still unresolved origin of somatically mutated IgM^+^ B cells in humans, we analyzed mutations in the *Bcl6* gene as a genetic trait of a previous GC experience. These mutations are found in ∼30% of GC B cells and class-switched memory B cells and show key features of SHM ([@bib26]; [@bib36]). As the mutation frequency in *Bcl6* is ∼50--100-fold lower than the one of IgV genes ([@bib26]), this explains why such mutations are not found in all class-switched memory B cells. Importantly, SHM is strictly dependent on transcription of its target genes ([@bib10]; [@bib3]; [@bib47]). On this basis, we reasoned that *Bcl6* mutations should only be present in IgM^+^ B cells with mutated IgV genes when these cells acquire their mutations in a GC reaction, i.e., when *Bcl6* is strongly transcribed ([@bib15]). Indeed, although there is a low basal level of *Bcl6* transcription in mature resting naive human B cells ([@bib49]), this is further reduced when the cells undergo TI immune responses outside GC ([@bib2]; Toellner, K.-M., personal communication). Thus, *Bcl6* should not acquire mutations in case SHM would be active in TI responses. We cannot formally exclude that Bcl-6 is transcribed during the proposed primary V gene diversification pathway for the generation of somatically mutated IgM^+^IgD^+^CD27^+^ B cells; however, this seems very unlikely considering that Bcl6 is the master regulator of the GC B cell differentiation program ([@bib15]).

As somatic mutations in IgV genes and *Bcl6* are generated by the same SHM machinery ([@bib26]), one would expect that their levels are correlated, and this is exactly what we observed. Both IgM^+^CD27^+^ B cell subsets have ∼50--60% of the mutation load of class-switched memory B cells in their IgV genes and in *Bcl6*. In conclusion, the detection of *Bcl6* mutations in IgM^+^IgD^+^CD27^+^ and IgM-only B cells strongly argues that most if not all of these cells derive from a GC reaction.

Derivation of IgM^+^IgD^+^CD27^+^ and IgG^+^CD27^+^ B cells from common GC B cell clones
----------------------------------------------------------------------------------------

If one assumes that IgM^+^IgD^+^CD27^+^ and IgG^+^CD27^+^ B cells derive from common GC B cell clones, and hence both represent post-GC memory B cells, finding of clonally related IgM^+^ and IgG^+^ PB B cells would represent an important validation for this assumption. However, a clonal relationship as such does not discriminate between the three proposed origins of somatically mutated IgM^+^IgD^+^CD27^+^ B cells. If these cells acquire IgV gene mutations during an antigen-independent primary diversification process, these cells may also enter GC reactions upon TD activation and give rise to IgG^+^ memory B cells. Even if IgM^+^IgD^+^CD27^+^ B cells represent GC independent memory B cells from TI immune responses, such cells may, in particular circumstances, be driven into GC reactions and become IgG^+^ memory B cells. It is only the mutation pattern within a clone that can discriminate between the different scenarios. Several of the clones are indeed unhelpful in clarifying this issue. In three clones shown in [Fig. 2 (I, K, and L)](#fig2){ref-type="fig"}, all IgG^+^ clone members may potentially derive from one prediversified IgM^+^ B cell or a memory B cell from a TI response that was driven into a GC reaction. However, in two other clones ([Fig. 2 H](#fig2){ref-type="fig"}) such a scenario is already less likely, as here one would have to postulate that two different members of a prediversified clone were driven into GC reactions. Importantly, the pattern of mutation accumulation in the other 10 clones ([Fig. 2, A--G and M--O](#fig2){ref-type="fig"}) is incompatible with a non-GC dependent scenario. In these clones, IgG and IgM members are intermingled in the genealogical trees, and some of the IgG cells can be found at earlier branches in the trees than IgM members, despite a number of shared mutations. Thus, in these clones IgG^+^ and IgM^+^ members coevolved from a common GC B cell clone.

The selective search for clonally related IgG^+^CD27^+^ and IgM^+^IgD^+^CD27^+^ B cells does not allow one to determine whether all or only a small fraction of IgM^+^IgD^+^CD27^+^ B cells were generated in GC reactions. Nevertheless, the fact that we found clonally related IgM^+^IgD^+^CD27^+^ B cells for ∼40% of the informative IgG^+^ memory B cells (in total, 14 of 37 Cγ transcript sequences tested with monoclonal Cμ or Cδ amplificates) indicates that GC B cell clones regularly give rise to both IgM and IgG memory B cells. That we did not find IgM^+^ members for all clones may simply be caused by technical matters (e.g., mutations in IgM^+^ clone members at primer binding sites) or a smaller size of many memory B cell clones, so that in the aliquot of PB that we analyzed no IgM members were present (note that we sampled ∼10% of PB B cells, but as only 2% of lymphocytes are present in PB \[[@bib7]\], overall we analyzed only an aliquot of 0.2% of B cells). Moreover, it is remarkable that in many of the clones the number of (distinct) members was similar for IgM^+^ and IgG^+^ B cells, which indicates that for at least half of the IgG^+^ memory B cells a population of clonally related IgM^+^ memory B cells of similar size exists. Considering that the frequency of IgG^+^ memory B cells in the PB is similar to the frequency of IgM^+^CD27^+^ B cells, this, together with the results of the *Bcl6* mutation analysis, suggests that indeed most if not all of the IgM^+^CD27^+^ B cells in human adults are post-GC B cells.

How do these findings relate to the indications for a generation of somatic mutations in IgM^+^IgD^+^CD27^+^ (and IgM-only) B cells by a prediversification mechanism or in the course of TI immune responses? Regarding an origin of IgM memory B cells from TI responses, it may well be that a small fraction of these cells were indeed generated in such immune reactions. However, the reported specific dependence of IgM memory B cells from the spleen with its marginal zone, and hence the association with TI type II responses ([@bib18]), was not seen in several other studies ([@bib46]; [@bib42]; [@bib24]), and there is evidence from studies in rodents that the marginal zone is also a reservoir for post-GC memory B cells ([@bib21]; [@bib38]), so a relationship between PB IgM^+^CD27^+^ B cells and splenic marginal zone B cells does not argue against a GC derivation of the cells. Regarding the evidence for a prediversification mechanism in IgM^+^IgD^+^CD27^+^ B cells, the recent description of a small population (3--5% of IgD^+^ B cells) of somatically mutated IgM^+^IgD^+^CD27^+^ B cells in fetal tissues indeed argues for a GC-independent development of these cells ([@bib33]). Importantly, however, only ∼20% of these fetal IgM^+^CD27^+^ B cells harbor somatic mutations, and the mutation load in these mutated cells was only about half of that of IgM^+^IgD^+^CD27^+^ B cells in adults ([@bib17]). Another main argument for a GC-independent origin of mutated IgM^+^IgD^+^CD27^+^ B cells relates to their presence in children affected by the x-linked hyper IgM syndrome ([@bib45]). However, in these patients only a fraction of IgM^+^IgD^+^CD27^+^ B cells carried mutated V genes, and a recent study indicated that the mutation frequency of the mutated V genes is often considerably lower than that of the corresponding B cells from healthy individuals ([@bib22]). Moreover, in x-linked hyper IgM patients, there could be an unphysiological expansion of the prediversified IgM^+^IgD^+^CD27^+^ B cells in the absence of competition with a normal population of memory B cells for survival niches. Finally, it may also be that GC-like structures exist in such patients and that memory B cells generated in such structures preferentially give rise to IgM^+^IgD^+^CD27^+^ B cells in the absence of CD40-triggering for class-switching. Taking these considerations together, a picture is emerging in which some IgM^+^IgD^+^CD27^+^ B cells are initially generated during early development in a primary antigen-independent diversification process, with a relatively low mutation load. Later in life, the majority of cells with this phenotype appear to derive from GC reactions and hence represent post-GC memory B cells.

Dynamics of memory B cell generation in the GC
----------------------------------------------

The detection and characterization of rearranged IgV genes from memory B cell clones not only showed that IgG^+^ and IgM^+^IgD^+^CD27^+^ memory B cells can derive from the same GC B cell clone, but provided additional insights into the dynamics of memory B cell generation in the human. First, GC B cell clones give rise to memory B cells throughout the GC reaction, and begin to do so very early in the response, as evident from PB memory B cells with very few or even a lack of IgV gene mutations. This finding provides evidence that lowly mutated memory B cells are not derived from particular immune reactions associated with diminished V gene diversification and/or hampered T cell help. Moreover, the detection of unmutated members of memory B cell clones might indicate that the few unmutated B cells that were described in previous V gene studies of CD27^+^ B cells are (mostly) memory B cells and not cell sorting contaminants. Also class switching is initiated very early during the clonal expansion, as multiple IgG^+^ clone members with few somatic mutations were detected. Second, the population of memory B cells generated from a GC B cell clone is often very diverse in terms of V gene sequences. This implies that memory B cells with a wide spectrum of affinities and antigen-binding characteristics is generated from a GC B cell clone. This might facilitate the recognition of slightly modified pathogens in recall responses by the memory B cell pool. Third, although IgM and IgG cells are often found intermingled in the genealogical trees, there is a clear tendency that IgM^+^ memory B cells were generally generated earlier than IgG^+^ memory B cells and hence show a lower overall mutation load (4.2% for IgM^+^ cells versus 6.2% for IgG^+^ memory B cells). These values are the same as those determined previously for the populations of IgM^+^IgD^+^CD27^+^ and IgG^+^ memory B cells ([@bib17]). Therefore, our analysis of clonally related IgM^+^IgD^+^CD27^+^ and IgG^+^ memory B cells indicates that a main determinant for the lower mutation load of the mutated IgM^+^ B cells is their earlier generation during GC reactions, and not, for example, a generation in separate, perhaps less efficient GC responses.

Concluding remarks
------------------

The results of the present study indicate that there is a large population of IgM^+^ memory B cells in human adults. Although the lower mutation load of these cells as compared with class-switched memory B cells may imply that the antibodies produced by these cells are usually of lower affinity that the one of IgG antibodies, this may be compensated for by the higher avidity of the pentameric IgM complexes when B cells differentiate into plasma cells and secrete antibody. Moreover, these memory B cells may serve as a flexible memory B cell reservoir that may reenter GC upon encounter with the same or a similar antigen to undergo further affinity maturation and be able to switch the isotype of their BCR to the needs of the particular recall response.

Besides the importance of revealing the origin of about a quarter of the human B cell pool, the present work also has important implications regarding the origin and consequence of dysregulated B cells in autoimmune diseases and immunodeficiencies, as well as B lymphoid malignancies. For example, many mature B cell lymphomas with somatically mutated IgV genes express IgM (and often also IgD), and the present study therefore supports the view that these are GC B cell--derived lymphomas ([@bib19]).

MATERIALS AND METHODS
=====================

### Cell separation.

Buffy coats of healthy adult donors were obtained from the blood bank of the Institut für Transfusionsmedizin of the Medical School of the University of Duisburg-Essen. Donors for full blood donations were recruited from the Medical School. All samples were collected with informed consent of the donors. The study protocol was approved by the Internal Review Board in Essen. PB mononuclear cells were isolated by Ficoll-Paque density centrifugation, and CD19^+^ B cells were enriched to \>98% by magnetic cell separation using the MACS system (Miltenyi Biotec).

### Cell sorting.

The B cell--enriched cell suspensions were stained with CD27-APC (eBioscience), anti--human IgD-PE, and IgM-FITC or IgG-FITC antibodies (all from BD). B cell subpopulations were sorted with a FACSDiva cell sorter (BD) as naive B cells (IgM^+^IgD^+^CD27^−^), class-switched memory B cells (IgG^+^CD27^+^), IgM^+^IgD^+^CD27^+^ B cells (IgM^+^IgD^+^CD27^+^), and IgM-only B cells (IgM^+^IgD^−/low^CD27^+^). Purity was \>99% for each population as calculated by reanalysis on a FACSCanto flow cytometer (BD) in combination with FACSDiva software.

### *Bcl6* mutation analysis.

Single cells were sorted into Expand High Fidelity PCR buffer (Roche) and incubated with 0.25 mg/ml proteinase K for 2 h. A semi-nested PCR strategy was used to amplify the *Bcl6*-MMC with a length of 744 bp ([@bib26]). The first round of amplification was performed in 2.5 mM MgCl~2~, 125 µM dNTPs, 0.125 µM each primer (5′-CGCTCTTGCCAAATGCTTTGGC-3′ and 5′-CTCTCGTTAGGAAGATCACGGC-3′), and 1.2 U High Fidelity DNA polymerase mix (Roche). For the second round of amplification, 1.5 µl of the first round reaction were used as template. PCR conditions were 1.75 mM MgCl~2~, 67 µM dNTPs, 0.125 µM each primer (5′-CGCTCTTGCCAAATGCTTTG-3′ and 5′-GACACGATACTTCATCTCATC-3′), and 1.2 U Fermentas Taq DNA polymerase. For sequence analysis, PCR products were purified with EZNA Cycle pure kit (VWR International GmbH) and sequenced from both strands with second round amplification primers. The procedure was accomplished using the ABI Cycle Sequencing Kit, version 3.1 on an ABI3130 Sequencer (Applied Biosystems). Sequence analysis was performed using the SeqScape software version 2.5 (Applied Biosystems) and the GenBank data library. To calculate whether one or two alleles were amplified from a cell, donors were prescreened for heterozygosity of a known monoallelic SNP in the *Bcl6*-MMC, a 1-bp deletion (rs3832246).

### Clonal relation in PB B cells: PAGE strategy.

IgG^+^CD27^+^ B cells and IgM^+^IgD^+^CD27^+^ B cells were sorted (as described in the Cell sorting section) in 30,000 cell aliquots. RNA was extracted with RNeasy micro kit (QIAGEN) and RT was performed with Superscript-III-RT (Invitrogen) according to the manufacturer's protocol. For gene-specific RT of RNA from class-switched B cells, a primer was used that recognizes Cγ1 and Cγ3 (5′-AGGCAGCCCAGGGCCGCTGTGCC-3′), and for RNA from IgM^+^IgD^+^CD27^+^ B cells a mixture of a Cμ (5′-AGCCAACGGCCACGCTGCTCGTAT-3′) and a Cδ primer (5′-CATGCCAGGACCACAGGGCTGTTATC-3′) was used. The distance to the 3′ end of the rearranged J~H~ gene is identical for the three primers. V~H~1 family-specific cDNA was amplified in 1.5 mM MgCl~2~, 250 µM dNTPs, 0.125 µM each primer (VH1FR2 5′-GGTGCGACAGGCCCCTGGACAA-3′ and constant primers as in RT), and 1.2 U High Fidelity DNA polymerase mix (Roche) in 35 cycles. PCR products were precipitated, resolved in 10 µl formamide and heat-denatured at 95°C for 2 min. Samples were loaded in neighboring lanes of a 6% denaturing PAGE gel (19:1 acrylamide/bisacrylamide, 7 M urea in TBE buffer). The gel was stained with the Silver sequence DNA staining kit (Promega) according to the manufacturer's instructions. PCR products of equal size in both lanes were excised and watered O/N in 50 µl H~2~O. 5 µl were reamplified in additional 35 PCR cycles and sequenced with the VH1FR2 primer. Products with identical, monoclonal CDRIII in both populations were cloned using pGEM-T-Easy cloning kit (Promega) and sequenced to identify clone members ([Fig. 1 A](#fig1){ref-type="fig"}).

### Clonal relation in PB B cells: CDRIII-primer strategy.

From 1 to 1.5 × 10^6^ cell aliquots of IgG^+^CD27^+^ B cells and IgM^+^IgD^+^CD27^+^ B cells from donors 1--8 and of naive B cells from donors 7 and 8, cDNA was prepared as described in the previous section and amplified in 1.5 mM MgCl~2~, 250 µM dNTPs, 0.125 µM each primer (*V~H~6*FR1 5′-GGTGCGACAGGCCCCTGGACAA-3′ or *V~H~3-23*-leader peptide sequence 5′-TTTGGGCTGAGCTGGCTTTTTCTTGTG-3′ and either a Cγ RT-primer or nested primers for Cμ 5′-TCGTATCCGACGGGGAATTCTCACAG-3′ and Cδ 5′-GTTATCCTTTGGGTGTCTGCACCCTG-3′), and 1.2 U High Fidelity DNA polymerase mix (Roche) for 35 cycles. The cDNA of IgG^+^ B cells was cloned using the pGEM-T-Easy cloning kit (Promega), and multiple plasmids per cloning were sequenced. For 8--30 sequences of each donor, CDRIII-specific primers were generated. PCR conditions were determined that were suitable to amplify for most of the clone-specific primers products from the corresponding diluted plasmid preparations (5 ng/µl) in no more than 35 cycles. PCR for the detection of clonally related sequences from cDNA of IgM^+^IgD^+^CD27^+^ B cells and naive B cells from donors 7 and 8 was performed with the following conditions: 30 µl reaction mixture containing 1.5 mM MgCl~2~, 250 µM dNTPs, 0.125 µM each primer (V~H~6FR1 or *VH3-23* leader peptide primer and CDRIII-specific primer), primary denaturation step of 95°C for 4 min, followed by 35 cycles of 30 s at 95°C, 30 s at 62°C, 60 s at 72°C, and 5 min at 72°C. Resulting amplificates were cloned and multiple plasmids were sequenced. CDRIII-specific primers that amplified clonally related sequences in IgM^+^ B cells were in parallel used to amplify further clone members from IgG^+^ cDNA (see flowchart in [Fig. 1 B](#fig1){ref-type="fig"}). All distinct V~H~ gene sequences are available at Genbank/EMBL/DDBJ under accession nos. [FN562934](FN562934)--[FN562983](FN562983), [FN564030](FN564030), and [FN563492](FN563492)--[FN563831](FN563831).

### Mutation tree analysis.

Sequences with identical CDRIII were aligned by Clustal W (Megalign; DNAStar). The number of expected DNA polymerase errors per sequence was determined using the following formula: ∼200 bp sequenced × 70 PCR cycles × polymerase error rate (8.3 × 10^−6^/bp/cycle \[Roche\]) = 0.1. Neglecting the low number of 1 expected polymerase induced error per 10 sequences, all nucleotides that did not match germline configuration of the respective V~H~ gene were considered as mutations introduced by SHM. To create the IgV gene lineage trees, the sequences were manually positioned in genealogic order, rooted by the germline configuration and assuming that a high number of shared mutations in a sequence determines a late ancestor and vice versa. Each set of sequences was analyzed in parallel with the IgTree program ([@bib4]; provided by R. Mehr, Bar-Ilan University, Ramat Gan Israel). Each genealogic tree was constructed to obtain a minimal amount of branching points and mutation events. In case the particular sequence of single mutation events could not be determined (e.g., possible back mutations were not outweighed by shared mutations or shared mutations could as well be interpreted as independent events), the solution in favor of a higher number of shared mutations is shown. Importantly, the basic structure of the tree was not affected.

### Calculation of clonal sizes.

Assuming all members of a clone in the sorted cell aliquots were detected by the PCR-based strategy and counting repeatedly identified sequences as one, we calculated the potential clone size in the PB. For example, for the largest clone ([Fig. 2 M](#fig2){ref-type="fig"}, donor 7) for which we detected 37 members in the 3 × 10^6^ sorted CD27^+^ B cells, in the total PB with ∼1 × 10^9^ CD19^+^ B cells (10^8^ B cells in 500 ml PB, total blood volume of ∼5 liter), of which 29% were CD27^+^, this clone would have in 5 liter of PB a size of ∼3,600 B cells (37 × 10^9^ x 0.29: 3 × 10^6^). The sizes of the other clones were analogously determined.

### Online supplemental material.

Fig. S1 shows the V~H~ sequences obtained from the naive B cells of donors 7 and 8 using V~H~3-23-- and CDRIII-specific primers for clones M, N, and O. Fig. S2 shows five selected sequences of each clone (A-P), aligned to the germline configuration of the corresponding V-, D-, and J-segments. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20091087/DC1>.
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